Broad Spectrum Protection in a Single Dose

Haemophilus parasuis is an early colonizer of the upper respiratory tract of pigs1. Virulent strains of H. parasuis can invade the host and cause systemic lesions characterized by fibrinous polyserositis, arthritis, and meningitis.1 H. parasuis primarily affects young pigs 4-8 weeks of age but sporadic disease can be observed in adult pigs.1 Disease caused by H. parasuis has a sudden onset, short course and high morbidity and mortality rates.1

Clinical Signs1

Clinical signs are seen primarily in pigs 4-8 weeks old and include:

  • High fever (106.7ºF)
  • Lack of appetite
  • Severe coughing
  • Abdominal breathing
  • Swollen joints
  • Reluctance to rise
  • Paddling
  • Trembling

PARASAIL®Haemophilus Parasuis Vaccine

Newport Laboratories' avirulent live H. parasuis vaccine has undergone 5 years of research and development to ensure safety and efficacy. PARASAIL utilizes patented2 technology and offers veterinarians and producers H. parasuis protection in a single, convenient 1mL dose.

1. Kahn CM. Glässer's Disease. The Merck Veterinary Manual. Tenth Edition. Whitehouse Station, NJ: Merck & Co., Inc.; 2010:653-654.

2. Oliveira SR, Simonson RR, Mahlberg JD, Titus MD, Oleson TA, inventors; Modified live Haemophilus parasuis vaccine. US patent 8,404,253. March 26, 2013.

PDF for Download: 

Randy Shirbroun talks pathology and prevention of diseases

  • by
  • Jun 24, 2016

WORTHINGTON, Minn. – Veterinarian Randy Shirbroun of Newport Laboratories Inc. addressed more than 200 bison producers regarding the pathology and prevention of diseases caused by Mycoplasma bovis. The producers had gathered for the 2016 National Bison Association Summer Conference held in June at Elk River, Minnesota. Shirbroun specializes in ruminant health issues including those seen in the American bison, which became the official U.S. national mammal in May.